QRISK2 Score by Age: What to Expect at Different Life Stages

Age is the single most powerful predictor of cardiovascular risk in the QRISK2 and QRISK3 algorithms. Understanding how your score is likely to change across different life stages, and what you can do to slow that progression, is one of the most practically useful aspects of cardiovascular risk assessment. This article explains the relationship between age and QRISK2 score clearly.

Why Age Has Such a Strong Effect on QRISK2 Scores

The relationship between age and cardiovascular risk is not simply a reflection of time passing, it reflects the cumulative biological effects of ageing on the cardiovascular system:

Arterial stiffness increases with age, arteries gradually lose their elasticity, raising systolic blood pressure and increasing cardiac workload
Endothelial function declines, the lining of blood vessels becomes less efficient at producing nitric oxide, a key vasodilator
Inflammatory burden accumulates, low-grade systemic inflammation increases with age, driving atherosclerosis
Lipid profiles shift, HDL (“good”) cholesterol tends to decline and LDL tends to rise with age in many individuals
Hormonal changes, oestrogen in women has cardioprotective effects; the menopause removes this protection, causing a significant rise in cardiovascular risk after approximately 50–55
Accumulated exposure to risk factors, the longer someone has lived with smoking, hypertension, high cholesterol, or diabetes, the greater the cumulative arterial damage

Typical QRISK2 Scores by Age Group

The following provides a general illustration, individual scores will vary significantly depending on the presence or absence of other risk factors. These are rough population averages for people without major additional risk factors:

Age 30–39: QRISK2 scores are typically very low, often well below 5%, in the absence of significant risk factors. However, a young person who smokes heavily, has type 1 diabetes, and a strong family history may already have a meaningfully elevated score.

Age 40–49: Scores begin to rise, typically in the 5–10% range for men without major risk factors. Women’s scores remain lower than men’s at this age due to the cardioprotective effects of oestrogen. This is the age at which the NHS Health Check is first offered (from age 40), and when risk factor management becomes particularly impactful.

Age 50–59: A significant inflection point, particularly for women. The menopause transition typically causes a rapid rise in cardiovascular risk markers, LDL cholesterol rises, HDL falls, and blood pressure often increases. Men in this age group with any additional risk factors may enter the 10–20% risk band.

Age 60–69: Without active risk factor management, many individuals in this age group have QRISK2 scores in the moderate-to-high range. Scores of 10–25% or above are common, and the risk-benefit calculation for statin therapy becomes particularly relevant for many patients.

Age 70–79: QRISK2 scores are often high even in relatively healthy individuals, because age itself carries such strong statistical weight in the algorithm. A healthy 75-year-old with well-controlled blood pressure and cholesterol may still have a score above 20% simply because the age coefficient is so large.

Age 80 and above: QRISK2 and QRISK3 have recognised limitations in their predictive accuracy at very advanced ages. The NHS does not typically recommend routine cardiovascular risk scoring using these tools above age 84.

The Sex Difference in Age-Related Cardiovascular Risk

The timing of cardiovascular risk accumulation differs significantly between men and women:

Men have higher absolute cardiovascular risk than women from early adulthood. A 45-year-old man will typically have a higher QRISK2 score than a 45-year-old woman with an otherwise identical risk factor profile.

Women experience a rapid acceleration of cardiovascular risk around the menopause, usually in their early-to-mid fifties. Post-menopausally, the sex difference in risk narrows substantially. By age 65–70, the gap in cardiovascular event rates between men and women is considerably smaller than in midlife.

This pattern means that cardiovascular risk assessment and intervention for women should be given particular attention in the peri- and post-menopausal period.

How to Slow the Age-Related Rise in Your QRISK2 Score

While you cannot change your age, the rate at which your cardiovascular risk accumulates with age is substantially modifiable:

Manage blood pressure proactively from your 40s, even high-normal blood pressure sustained over two decades produces significant cumulative arterial damage.

Optimise your cholesterol ratio, not just lowering total cholesterol, but raising HDL through regular aerobic exercise and improving the total cholesterol-to-HDL ratio through diet.

Quit smoking at any age, the cardiovascular risk associated with smoking begins to fall within days of quitting and continues to fall for years.

Maintain physical activity, the cardioprotective effects of regular aerobic exercise are present at all ages, including in older adults.

Manage weight, the metabolic consequences of excess weight compound with age.

For women: discuss cardiovascular risk around menopause, hormone replacement therapy (HRT) may have cardiovascular effects (beneficial or otherwise depending on timing and formulation); this warrants a detailed individual discussion with your GP.

A Herbal Medicine Perspective on Age-Related Cardiovascular Risk

At Herba Naturalle, the age-related rise in cardiovascular risk is understood through the lens of accumulating smooth muscle lining inflammation in the blood vessels, a process that can be meaningfully slowed through targeted herbal and nutritional support alongside lifestyle measures.

Anjela Jeganathan’s clinical approach addresses the digestive, nervous system, and smooth muscle lining layers that collectively drive cardiovascular ageing. Products including the Berberis Plus and Marshmallow Root Plus are used as part of broader protocols supporting vascular and digestive health.

Read more at About Herbal Medicine or contact the clinic.

The Herba Naturalle 3-Step Bundle

The Herba Naturalle Bundle supports healthy ageing of the cardiovascular system through three steps:

Step 1, Restore Digestion: Healthy digestion and elimination reduce the inflammatory burden that accelerates cardiovascular ageing.

Step 2, Calm the Surface Nervous System: The Nervous System Reset reduces the chronic stress activation that drives age-related blood pressure rise and vascular inflammation.

Step 3, Heal the Smooth Muscle Lining: The Smooth Muscle and Immune Reset Bundle directly targets the arterial wall inflammation that drives the age-related increase in cardiovascular risk.

This article is for informational purposes only. Please consult your GP for a personal cardiovascular risk assessment at any age.